Overview
Siddhartha Sivaramakrishnan focuses his practice on the representation of APAC and EMEA investment bank underwriters, issuers and vendors in a wide range of US and international capital markets transactions. These include numerous equity and debt offerings under Rule 144A and Regulation S and SEC-registered offerings. Siddhartha also advises on M&A, de-SPAC and restructuring transactions.
Siddhartha counsels on financial institution regulatory and compliance matters, including cross border licensing and marketing requirements and insider dealing and market abuse. He also advises on corporate governance and reporting requirements.
Siddhartha operates from the firm’s Singapore and London offices.
Results
- Advised a Baltic gaming operator on its restructuring of its outstanding senior secured notes and related consent solicitation
- Advised Kotak, Citi, Nomura and Haitong on the US$ 872 million IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering of Gland Pharma, a leading generic injectables manufacturer majority owned by global pharmaceutical major Shanghai Fosun Pharma*
- Advised Credit Suisse, Bank of America and UBS as joint sponsors on the US$ 1.31 billion SEC-registered global offering and secondary listing on the Hong Kong Stock Exchange of New Oriental Education and Technology, China’s largest private educational service provider*
- Advised State Grid Corporation China, the world’s largest utility corporation, on its US$7.7 billion and US$10 billion MTN programmes and drawdowns of US$5 billion and US$2.1 billion, respectively*
- Advised Carlyle as selling shareholder on the US$1.4 billion IPO and Rule 144A/Regulation S global offering of SBI Cards, India’s second largest credit card issuer*
- Advised Wijaya Karya, an Indonesian engineering and construction major, on its IDR 5,400 billion (US$400 million) global offering of rupiah denominated, dollar settled komodo bonds, the largest such issuance as of its date. BNP, HSBC, Mandiri and MUFG were the initial purchasers*
- Advised a US private equity fund on its UK listing of notes secured by certain loan receivables
- Advised Citi, Deutsche Bank and UBS as international selling agents on the US$276 million IPO on the Indonesia Stock Exchange and Rule 144A/ Regulation S global offering by Cikarang Listrindo, an independent power producer*
- Advised Khazanah, the Malaysian sovereign wealth fund, on its US$500 million Regulation S offering of exchangeable bonds. CIMB, Credit Suisse and J.P. Morgan were the joint lead managers*
- Advised Maybank Kim Eng, UOB and DBS on the US securities law aspects of the SG$297 million IPO on the Singapore Stock Exchange and Regulation S international offering of Aztech Global, a technology hardware manufacturer*
- Advised Hibiscus Petroleum, a Malaysian oil and gas E&P company, on the US securities law aspects of its proposed US$490 million issuance of convertible preference shares to fund certain acquisitions*
- Advised a global investment fund on market manipulation regulations in various Asian and European jurisdictions*
- Advised an EMEA investment fund on its continuous reporting obligations in certain Asian jurisdictions*
*Matter handled prior to joining McDermott
Recognitions
- Chambers Global 2022, Capital Markets: International, Singapore and International, India
- Chambers Asia Pacific 2022, International Firms, India
- Chambers Asia Pacific 2021-2022, Capital Markets: International, Singapore
- Listed as an International A-List lawyer in India Business Law Journal, 2022
- Legal 500 2021, Capital Markets: Equity And Debt: Foreign Firms
- IFLR 1000 2021, Capital Markets Debt & Equity
Credentials
Education
Yale University
University of Oxford
Admissions
England & Wales
New York
